Mona Malz
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy.
Journal: Nature communications
Published: October 23, 2024
Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated.
Journal: Journal of medicinal chemistry
Published: April 10, 2019
Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity.
Journal: ACS chemical biology
Published: December 22, 2015
PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.
Journal: Hepatology (Baltimore, Md.)
Published: June 29, 2015
Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cells.
Journal: The Journal of pathology
Published: February 06, 2015
Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: March 17, 2014
Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors.
Journal: Endocrine-related cancer
Published: December 24, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026